309 filings
Page 6 of 16
CORRESP
1n80vyr
4 Jun 21
Correspondence with SEC
12:00am
UPLOAD
0kfjt79uz
3 Jun 21
Letter from SEC
12:00am
8-K/A
r5ahl
1 Jun 21
Financial Statements and Exhibits
4:25pm
CORRESP
l4dp8a
28 May 21
Correspondence with SEC
12:00am
DEFA14A
dsraiaql6ouu0t
21 May 21
Additional proxy soliciting materials
4:10pm
8-K
hl279tyg2 ip1
21 May 21
Departure of Directors or Certain Officers
8:00am
8-K
toff64 3sm4wugtv93z4
17 May 21
Oncocyte Reports First Quarter 2021 Financial Results and Provides Corporate Update
5:19pm
D
06j2k kpiu5godgo
29 Apr 21
$17.5M in equity, sold $3.01M, 75 investors
4:44pm
8-K
bxrr4
19 Apr 21
Entry into a Material Definitive Agreement
1:44pm
8-K
j0awz3c9ns k2
16 Mar 21
Oncocyte Provides Corporate Update and Reports Fourth Quarter and Annual 2020 Financial Results
4:36pm
D
p25s06 e9sx1p9pgb0l
8 Mar 21
$5M in equity, sold $5M, 7 investors
4:13pm
CERT
jdpna8 udto3x5o7i2i
5 Mar 21
Certification of approval for exchange listing
1:43pm
25
72ck1
5 Mar 21
Voluntary exchange delisting
8:00am
8-A12B
d02ovn7x0r5s497q
1 Mar 21
Registration of securities on exchange
4:31pm